HRT Financial’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

HRT Financial’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,372	Closed	-$178K	–	3410
2023 Q2	$178K	Sell	17,372 -68	-0.4%	-$694	﹤0.01%	1874
2023 Q1	$176K	Buy	17,440 +500	+3%	+$5.04K	﹤0.01%	1950
2022 Q4	$168K	Hold	16,940	–	–	﹤0.01%	1978
2022 Q3	$164K	Hold	16,940	–	–	﹤0.01%	2270
2022 Q2	$164K	Buy	16,940 +193	+1%	+$1.88K	﹤0.01%	2310
2022 Q1	$163K	Buy	+16,747	New	+$162K	﹤0.01%	2542

HRT Financial's DALS Position: Q3 2023 in Review

HRT Financial sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 17,372 shares — an estimated $178K sold.

HRT Financial first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $178K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

HRT Financial reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 17,372 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $178K.
HRT Financial first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 6 quarters.
HRT Financial's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $178K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.